
KYOTO -- Takara Bio is preparing to produce 50 times more of a coronavirus testing reagent at its plant in Dalian in response to an urgent request from the Chinese city, where the Japanese drugmaker's main factory is located.
Takara Bio aims to churn out 250,000 units of the reagent per week and will supply it to 30 test kit manufacturers in 10 Chinese cities, including Wuhan, the epicenter of the outbreak.